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Background
Decreases in labor productivity due to health problems occur not only from an employee 
being absent from work or taking leave (absenteeism), but also from reduced produc-
tivity whilst at work (presenteeism), and this presents an important problem facing the 
field of occupational health. Presenteeism is defined as a reduced ability to perform at 
work due to health problems (Burton et  al. 1999). The losses businesses incur due to 
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presenteeism have been reported to eclipse the losses due to absenteeism (Loeppke 
et al. 2003, 2007; Goetzel et al. 2004). Therefore, investigation into the impact of specific 
health problems on presenteeism is very important for the creation of measures in the 
field of occupational health. For example, data attained from surveys on presenteeism is 
very beneficial for government and businesses for planning and assessing occupational 
health plans, and calculating the cost-effectiveness of the utilization of occupational 
health activities. However, although numerous reports on presenteeism arising from dis-
ease and treatment exist throughout the world (Koopmanschap et al. 2005; Schultz and 
Edington 2007; Pauly et al. 2008; Schultz et al. 2009; Bockerman and Laukkanen 2010; 
Brown et  al. 2011; Cocker et  al. 2011), there have been very few investigative reports 
conducted in Japan (Yamashita and Arakida 2006; Wada et al. 2007; Minami et al. 2010; 
Wada et al. 2013). Presenteeism is considered to be affected by working environments 
and work–life balance (Dew et al. 2005); thus, given that these differ according to coun-
try and culture, the accumulation of data on presenteeism in Japan is considered to be 
essential to the field of occupational health in Japan.
There are numerous reports on the beneficial effects of pharmaceuticals on presentee-
ism (Schultz et al. 2009); however, there are no investigative reports that focus on the 
impact of the side effects of pharmaceuticals on presenteeism. In recent years, in accord-
ance with advances in healthcare cost containment and home healthcare, the adminis-
tration of anticancer drugs has transitioned from inpatient care to outpatient clinics, and 
outpatient chemotherapy is now widely practiced. The side effects associated with anti-
cancer drugs affect the quality of life (QOL) of cancer patients (Fallowfield et al. 2006; 
Taira et al. 2014; Tachi et al. 2015). We hypothesize that, in addition to a reduction in 
QOL, presenteeism is increased in patients receiving outpatient chemotherapy. Thus, 
presenteeism due to the side effects of chemotherapy could potentially become a signifi-
cant problem for the occupational health field.
The incidence of breast cancer has been increasing. The majority of cases occur in 
women in their late 50s, but there has been an increasing number of cases in women 
in their late 20s (National Cancer Center 2001; National Cancer Institute 2014). With a 
comparatively younger generation of women affected by breast cancer, a growing num-
ber of patients receive outpatient chemotherapy while continuing their employment. In 
a previous report, we demonstrated that the side effects of anticancer drugs decrease 
the QOL of breast cancer patients receiving outpatient chemotherapy (Tachi et al. 2015; 
Tanaka et  al. 2015). We hypothesize that, due to the side effects, QOL decreases and 
presenteeism increases for workers receiving outpatient chemotherapy.
The objective of this prospective study was to clarify, via questionnaire, the impact 
of the side effects of anticancer drugs on presenteeism in workers receiving outpatient 
chemotherapy for breast cancer.
Methods
Subjects
All currently employed breast cancer patients who received outpatient chemotherapy for 
the first time at Gifu Municipal Hospital, Japan, between December 2012 and November 
2013 were enrolled in this study. Outpatient chemotherapy for breast cancer patients is 
changing rapidly because novel anti-cancer drugs, regimens, and supportive therapies 
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have been developed. Furthermore, chemotherapy has shifted from inpatient to outpa-
tient settings due to the medical cost reduction induced by the Japanese government. In 
order to reduce the influence of this shift and focus on current outpatient chemotherapy 
in Japan, we selected the limited study period of 1 year over the sample size.
Survey method
The survey questionnaire was conducted before and after a single course of outpatient 
chemotherapy.
The pre-treatment questionnaire consisted of the Japanese edition of the EuroQol 5 
Dimension (EQ-5D) (EuroQol Group 1990; Okamoto et  al. 2004), the Quality of Life 
Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD) (Shimo-
zuma et al. 1994; Kurihara et al. 1999), and items regarding patient attributes, such as 
marital status, whether they lived alone or with others and the number of people in their 
household, current employment, employment before diagnosis, education, income, and 
whether they were health personnel.
The post-treatment questionnaire consisted of the EQ-5D, the QOL-ACD, and items 
concerning the side effects of anticancer drugs, absenteeism, and presenteeism (Fig. 1). 
The questions concerning presenteeism were based on the Work Productivity and Activ-
ity Impairment Questionnaire General Health v2.0 (WPAI-GH) (Reilly et  al. 1993). In 
our study, questionnaire research was performed after 1 course of chemotherapy during 
which we were able to obtain comprehensive information regarding the conditions.
In addition, we collected data regarding the patients’ age, TNM breast cancer staging, 
performance status (PS), human epidermal growth factor receptor type 2 (HER2), estro-
gen receptor (ER), progesterone receptor (PgR), the purpose of anticancer drug treat-
ment, and the treatment regimen from electronic medical records.
Analytical methods and statistical processing
QOL was evaluated with the utility value and ratio of persons with problems for each of 
the 5 items calculated from the EQ-5D, and the total score of all items and the average 
score of each subscale obtained from the QOL-ACD.
For evaluating absenteeism and presenteeism arising from anticancer drug treatment, 
we used national statistical data from the 2012 Basic Survey on Wage Structure (i.e., 
daily working time and wages for regular and non-regular staff by age) published by the 
Ministry of Health, Labour and Welfare of Japan (2012), and data from our question-
naire (i.e., daily wage calculated from the average annual income based on the question-
naire results) (August 21, 2015: 1 USD = 122.5 yen, 1 euro = 138.6 yen].
Absenteeism
Presenteeism
Rate of labor loss (%) = daily hours lost (h)/daily working time
[national statistical data](h)
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Amount of labor loss (for absenteeism or presenteeism)








× rate of labor loss (%)/100
Fig. 1 Content of the post‑treatment questionnaire
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Daily working time calculated from the national statistical data was used for evaluat-
ing absenteeism, as substitute for the sum of working time obtained from a question-
naire because of variations in the working days per week for people in Japan.
Furthermore, to account for the losses associated with both absenteeism and presen-
teeism, we summed the losses due to absenteeism and the losses due to presenteeism 
after deducting the losses through absenteeism.
SPSS 22 software (IBM, Armonk, NY, USA) was used for statistical analysis. A paired 
t test was used to test the difference between the total score from the QOL-ACD and 
average score for each subscale, and the utility value before and after 1 treatment course. 
Fisher’s exact test was used for the between-group comparisons to evaluate the effect 
of the presence or absence of each side effect on the ratio of patients whose condition 
had deteriorated before and after treatment according to the 5 items in the EQ-5D. The 
Mann–Whitney U test was used to evaluate the differences in the changes in the QOL, 
absenteeism, and presenteeism between before and after chemotherapy stratified by the 
presence or absence of each side effect. Spearman’s rank correlation analysis was used 
to evaluate the correlations between absenteeism or presenteeism, and QOL. A value of 
p < 0.05 was considered statistically significant.
Ethics
This study was conducted in accordance with the Declaration of Helsinki and other Japa-
nese research guidelines. The study protocol was approved by the ethics committee of 
Gifu Pharmaceutical University and Gifu Municipal Hospital (Bioethics Committee of 
Gifu Pharmaceutical University, Research Ethics Committee No. 128, respectively). The 
study documents were explained to the patients and letters of informed consent were 
acquired prior to enrolment. Furthermore, the patients participated in the study vol-




All enrolled patients (n = 19) answered the questionnaire twice and no patients declined 
to participate in the survey. The patient characteristics are shown in Table 1. The patients 
were all women with a mean age of 55.6 years. Of the 19 patients, 36.8 % had stage 1 
breast cancer, and 100 % had a PS value of 0. Seven patients (36.8 %) were HER2-(3+), 
13 (68.4 %) were ER-positive, and 12 (63.2 %) were PgR-positive. The most widely used 
treatment regimen was EC (epirubicin/cyclophosphamide) chemotherapy using epiru-
bicin and cyclophosphamide (42.1  % of patients). Furthermore, 73.7  % of the patients 
were married and 100 % lived with at least one other person in their household. All par-
ticipants were currently employed, and their employment status had not changed from 
before diagnosis. The majority of patients worked part-time or had temporary employ-
ment (52.6 %), 31.6 % of patients were employed full-time or self-employed, and 15.8 % 
of patients did not fit into either category.








× rate of labor loss (%)/100
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Table 1 Patient attributes
Mean ± SD
Age (year) 55.6 ± 9.7
n %
Stage
 1 7 36.8
 2 6 31.6
 3 4 21.1
 4 2 10.5
TNM classification
 T1, N0, M0 8 42.1
 T2, N0, M0 3 15.8
 T2, N1, M0 2 10.5
 T4, N0, M0 2 10.5
 T4, N2, M0 2 10.5
 T4, N0, M1 2 10.5
PS
 0 19 100.0
HER2
 3+ 7 36.8
 2+ 1 5.3
 1+ 7 36.8
 (−) 4 21.1
ER
 (+) 13 68.4
 (−) 3 15.8
 (±) 3 15.8
PgR
 (+) 12 63.2
 (−) 3 15.8
 (±) 4 21.1
Purpose of chemotherapy
 Adjuvant 7 36.8
 Neoadjuvant 11 57.9
 Symptom relief 1 5.3
Regimen
 EC (every 3w) 8 42.1
 TRZ + nabPTX (every 3w) 3 15.8
 TC (every 3w) 2 10.5
 3w‑nabPTX (every 3w) 3 15.8
 LPR (every 4w) 3 15.8
Marital status
 Married 14 73.7
 Unmarried 5 26.3
Cohabitants
 Yes 19 100.0
 No 0 0.0
Current occupation
 Temporary employment, part‑time employment 10 52.6
 Company employee, self‑employed 6 31.6
 Public official 0 0.0
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QOL assessment
The QOL as assessed by the EQ-5D before and after 1 treatment course is shown in 
Table 2. The utility value decreased significantly after treatment (p < 0.001). Specifically, 
there was a significant increase in the number of patients who experienced problems 
with usual activities after treatment (p = 0.020).
The QOL as assessed by the QOL-ACD before and after 1 treatment course is shown 
in Table  3. The total score for the QOL-ACD decreased significantly after treatment 
(p = 0.045). For the QOL-ACD subscales, the mean scores for activity and physical con-
dition decreased significantly after treatment (p =  0.021 and p =  0.003, respectively); 
Table 1 continued
n %
 Other 3 15.8
Current annual income
 0–999,999 yen 10 52.6
 1,000,000–4,999,999 yen 7 36.8
 5,000,000–9,999,999 yen 2 10.5
 10,000,000– yen 0 0.0
Occupation before diagnosis
 Temporary employment, part‑time employment 10 52.6
 Company employee, self‑employed 6 31.6
 Public official 0 0.0
 Other 3 15.8
Education
 Junior school graduate 3 15.8
 High school graduate 7 36.8
 Vocational school, junior college, technical school graduate 8 42.1
 University graduate, postgraduate 1 5.3
Experience as a healthcare professional
 Currently a healthcare professional 0 0.0
 Was a healthcare professional in the past 1 5.3
 Was not a healthcare professional in the past 18 94.7
SD standard deviation, PS performance status, HER2 human epidermal growth factor receptor type 2, ER estrogen receptor, 
PgR progesterone receptor, EC epirubicin/cyclophosphamide, TC docetaxel/cyclophosphamide, TRZ trastuzumab, LPR 
leuprorelin, nabPTX nab-paclitaxel, 3w 3 weeks, 4w 4 weeks




Before CT After CT p
Utility value 0.907 ± 0.128 0.771 ± 0.125 <0.001*
Dimensions Some or major problems (%)
 Mobility 5.3 15.8 0.604
 Personal care 0 0 1.000
 Usual activities 0 31.6 0.020*
 Pain/discomfort 21.1 42.1 0.295
 Anxiety/depression 26.3 57.9 0.099
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however, a significant increase in the mean score was observed for social relationships 
(p = 0.010).
Subjective side effects
The following side effects were reported by the patients: weariness or fatigue (68.4 %), 
nausea or vomiting (31.6 %), diarrhea (10.5 %), constipation (47.4 %), dizziness or stag-
gering (21.1 %), numbness or unusual feelings in hands or feet (42.1 %), and other side 
effects (47.4 %).
Assessment of absenteeism and presenteeism
The losses in productivity and costs due to absenteeism and presenteeism are shown 
in Table 4. The rate of absenteeism was 24.7 %, resulting in 1.79 h/day of lost working 
hours and a financial loss of 2002 and 881 yen/day according to national statistical and 
our questionnaire data, respectively. The rate of presenteeism was 33.7 %, resulting in 
financial losses of 1354 and 1263 yen/day according to national statistical and our ques-
tionnaire data, respectively. Furthermore, when absenteeism and presenteeism were 
Table 3 The QOL-ACD total score and  mean score for  each subscale before  and after  1 
course of outpatient chemotherapy
CT chemotherapy, mean ± standard deviation
*p < 0.05
Before CT After CT p
Total score 93.6 ± 6.9 89.1 ± 9.9 0.045*
Average score of subscales
 Activity 4.83 ± 0.32 4.45 ± 0.77 0.021*
 Physical condition 4.60 ± 0.27 4.11 ± 0.56 0.003*
 Psychological condition 4.28 ± 0.52 3.98 ± 0.66 0.077
 Social relationships 2.43 ± 0.65 2.81 ± 0.70 0.010*




 Loss of labor time 1.79 ± 2.92 (h/day)
 Rate of labor loss 24.7 ± 39.1 (%)
 Amount of labor loss
  Calculated according to national statistical data 2002 ± 3374 (yen/day)
  Calculated according to the questionnaire data 881 ± 1883 (yen/day)
Presenteeism
 Rate of labor loss 33.7 ± 33.7 (%)
 Amount of labor loss
  Calculated according to national statistical data 1354 ± 1907 (yen/day)
  Calculated according to the questionnaire data 1263 ± 1960 (yen/day)
Absenteeism + Presenteeism
 Amount of labor loss
  Calculated according to national statistical data 3356 ± 3796 (yen/day)
  Calculated according to the questionnaire data 2144 ± 2623 (yen/day)
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assessed together, the total cost of productivity loss was 3356 and 2144 yen/day accord-
ing to national statistical and our questionnaire data, respectively.
The correlation between absenteeism or presenteeism and QOL is shown in Table 5. 
A significant positive correlation was observed between absenteeism and presentee-
ism (r = 0.687, p = 0.001). Furthermore, significant negative correlations were observed 
in post-treatment changes between the QOL-ACD scores and absenteeism or presen-
teeism (absenteeism: r = −0.528, p = 0.020; presenteeism: r = −0.625, p = 0.004). No 
significant correlations were observed between absenteeism or presenteeism and post-
treatment changes in the EQ-5D scores.
The correlation between absenteeism or presenteeism and the QOL based on the 
subscales of the QOL-ACD is shown in Table 6. A significant negative correlation was 
observed between absenteeism or presenteeism and post-treatment changes in the 
activity subscale score in the QOL-ACD (absenteeism: r = −0.570, p = 0.011; presentee-
ism: r = −0.736, p < 0.001); however, no significant correlations were observed for the 
other subscale scores.
The changes in the QOL, absenteeism, and presenteeism between before and after 
chemotherapy, stratified by the presence or absence of each side effect, are shown in 
Table 7. Diarrhea and dizziness or staggering were not evaluated because of the small 
sample size of patients with the side effects. The reduction in the QOL-ACD and activity 
Table 5 Correlations among absenteeism, presenteeism and quality of life
Absenteeism and presenteeism represent respective rates of labor loss, ΔEQ-5D and ΔQOL-ACD represent respective 
changes in utility value before and after a course of chemotherapy, and changes in the total QOL-ACD score
# Spearman’s rank correlation coefficient, *p < 0.05
Adverse events Correlation coefficient# p
Absenteeism versus Presenteeism 0.687 0.001*
Absenteeism versus ΔEQ‑5D 0.273 0.258
Absenteeism versus ΔQOL‑ACD −0.528 0.020*
Presenteeism versus ΔEQ‑5D 0.169 0.489
Presenteeism versus ΔQOL‑ACD −0.625 0.004*
Table 6 Correlations between  absenteeism and  presenteeism, and  quality of  life (sub-
scales of QOL-ACD)
Absenteeism and presenteeism represent respective rates of labor loss, ΔActivity, ΔPhysical condition, ΔPsychological 
condition and ΔSocial relationships represent respective changes in average scores of QOL-ACD subscales (Activity, Physical 
condition, Psychological condition and Social relationship)
# Spearman’s rank correlation coefficient, *p < 0.05
Adverse events Correlation coefficient# p
Absenteeism versus ΔActivity −0.570 0.011*
Absenteeism versus ΔPhysical condition −0.296 0.219
Absenteeism versus ΔPsychological condition −0.240 0.322
Absenteeism versus ΔSocial relationships −0.224 0.357
Presenteeism versus ΔActivity −0.736 <0.001*
Presenteeism versus ΔPhysical condition −0.429 0.067
Presenteeism versus ΔPsychological condition −0.163 0.505
Presenteeism versus ΔSocial relationships −0.184 0.450
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was significantly greater in patients with nausea or vomiting than in those without nau-
sea or vomiting (respectively, p = 0.046 and p = 0.005). The changes in the other sub-
scale scores in the QOL-ACD, absenteeism, and presenteeism were not significantly 
different between those with and without the other side effects.
Discussion
We conducted a questionnaire-based prospective analysis to investigate the impact of 
the side effects of anticancer drugs on presenteeism in working patients receiving outpa-
tient chemotherapy for breast cancer. Furthermore, we assessed the correlation between 
presenteeism or absenteeism due to treatment side effects and changes in QOL.
The majority of the patients in this study had stage 1 breast cancer and was ER-positive 
and PgR-positive, which was consistent with the statistical data in Japan (The Japanese 
Breast Cancer Society 2012). A high number of patients had a PS value of 0 and HER2-
(3+), underwent chemotherapy as neoadjuvant therapy, and were administered the EC 
regimen for chemotherapy compared to the statistical data in Japan (The Japanese Breast 
Cancer Society 2012), which included chemotherapy patients and those who did not 
receive chemotherapy in an outpatient setting. The demographics of this study would be 
similar to the distribution of breast cancer patients receiving outpatient chemotherapy 
in Japan. The percentage of temporary and part-time workers was 52.6  %, which cor-
respond to the present Japanese labor market (45.9 %) (Ministry of Health, Labour and 
Welfare of Japan 2011).
Significant reductions in the QOL were observed after 1 treatment course, accord-
ing to the total scores of the EQ-5D and QOL-ACD. There was a significant increase in 
patients who reported having difficulties with usual activities in the EQ-5D. The pres-
ence of problems in some dimensions was not significantly different between before and 
after chemotherapy, which might be due to the small number of patients. In addition, 
there might be the possibility of the influence of the diagnosis on the EQ-5D, especially 
depression/anxiety. The average scores for activity and physical condition decreased sig-
nificantly in the QOL-ACD after 1 treatment course. However, the average scores for 
social relationships increased significantly after 1 treatment course.
The loss of productivity due to absenteeism and presenteeism was 24.7 and 33.7  %, 
respectively. The estimated financial impact of lost productivity ranged 881–2002 and 
1263–1354 yen/day for absenteeism and presenteeism, respectively. Similar to absentee-
ism, there were significant productivity losses associated with presenteeism due to the 
side effects of chemotherapy. It has been reported that business losses from presenteeism 
were greater than that from absenteeism (Loeppke et al. 2003, 2007; Goetzel et al. 2004). 
According to our results, productivity losses due to presenteeism were at least similar in 
magnitude to that of absenteeism. Furthermore, the financial impact for both absentee-
ism and presenteeism was 2144–3356 yen/day, amounting to a 40–50 % loss in productiv-
ity per day. Therefore, the impact of absenteeism and presenteeism due to the side effects 
of chemotherapy are considered strongly significant. According to these results, side 
effects due to chemotherapy greatly led to both absenteeism and presenteeism.
A moderate positive correlation was observed between absenteeism and presentee-
ism, suggesting that employees with absenteeism are also likely to be affected by pres-
enteeism. A higher reduction in the QOL suggested a higher degree of absenteeism or 
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presenteeism based on the moderate negative correlation observed between absentee-
ism or presenteeism and post-treatment changes in the QOL (QOL-ACD). There were 
no corresponding significant correlations observed between absenteeism or presentee-
ism and post-treatment changes in the EQ-5D. Differences in the designs of these QOL 
measures may account for these findings. The QOL-ACD was developed specifically 
for cancer patients and consisted of 5-stage answers to 23 questions; while the EQ-5D 
was designed for the general population with 3-stage answers to 5 questions. Therefore, 
the measurement sensitivity of the QOL in the EQ-5D in cancer patients was consid-
ered to be lower than that in the QOL-ACD. Furthermore, a higher reduction in activ-
ity suggested a higher degree in absenteeism or presenteeism based on our observation 
of a moderate negative correlation between absenteeism and post-treatment changes in 
activity (QOL-ACD) and a strong negative correlation between presenteeism and post-
treatment changes in activity (QOL-ACD). Activity would be one of the factors deter-
mining the correlation between absenteeism or presenteeism and the QOL-ACD.
The reductions in the QOL-ACD and physical condition in patients with nausea or 
vomiting were significantly greater compared to those without side effects, suggesting 
that the QOL, especially their physical condition, was influenced by nausea and vomit-
ing due to chemotherapy. Presenteeism in patients with nausea or vomiting tended to be 
greater compared to those without the side effect, therefore nausea or vomiting might 
influence presenteeism. However, the changes in the other subscale scores of the QOL-
ACD, absenteeism, and presenteeism were not significant different between those with 
and without the other side effects. These results might occur due to limitations in sam-
ple size.
One of the limitations of our study is the small sample size (19 patients) owing to the 
single-site design. As explained earlier, we selected the limited period of 1  year over 
sample size, in order to reduce the influence of the shift in chemotherapy in Japan. The 
content validity of the questionnaire (the efficiency of question or questions to cor-
rectly express the content to be clarified in the study) might be another limitation in 
this study. In our study, presenteeism was evaluated, using an ordinal scale, by directly 
asking about work productivity during work as a single question. Therefore, the con-
tent validity of the questionnaire for evaluating presenteeism would be adequate in an 
exploratory research to investigate the impact of the side effects of anticancer drugs on 
presenteeism in workers receiving outpatient chemotherapy for breast cancer, especially 
in Japan. In the future, further investigations regarding the influence of the side effects of 
breast cancer chemotherapy on presenteeism should be conducted in a larger number of 
patients to verify the rigid content validity of the questionnaire. Moreover, our analysis 
was based on the acute phase side effects because we only included patients receiving 
chemotherapy for the first time. Given that chemotherapy is not usually completed in 
a single course, similar side effects can be expected with repeated sessions of chemo-
therapy. As the treatment continues and number of courses of chemotherapy increases, 
chronic phase side effects may emerge and the subsiding of acute side effects may be 
delayed. Therefore, it will be necessary to investigate the impact of long-term chronic 
and acute side effects of anticancer drugs in future studies about presenteeism. Further-
more, it will also be necessary to investigate this impact in specific subsamples (i.e., dif-
ferent age groups and types of chemotherapy) and to clarify the influence of the side 
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effects of chemotherapy for other types of carcinomas, in addition to breast cancer, on 
presenteeism.
As outpatient chemotherapy is becoming more common, the number of people receiv-
ing anticancer drug treatment while continuing to work is increasing. Therefore, the 
findings from this survey regarding presenteeism of patients receiving cancer treatment 
are important for improving occupational health of workers receiving chemotherapy 
for cancer. In previous studies, presenteeism is influenced by characteristics related to 
workers and workplaces (Bockerman and Ilmakunnas 2008), and working time match 
between desired and actual weekly working hours reduces presenteeism (Bockerman 
and Laukkanen 2010). Earlier evidence points to the fact that special attention should be 
paid to working time arrangements, workers’ replacement practices, attendance pressure 
factors, and personal attitudes (Aronsson et  al. 2000; Aronsson and Gustafsson 2005; 
Hansen and Andersen 2008). Therefore, the findings of our study can be helpful for plan-
ning a practical policy for workers receiving chemotherapy for cancer, such as industrial 
health control for workers, introduction of a leave system for workers by the govern-
ment, and subsidizing companies that promote the leave system from the government.
Conclusions
According to the findings of this prospective analysis, the side effects of anticancer drugs 
have a significant impact on presenteeism in workers receiving outpatient chemotherapy 
for breast cancer in Japan. Especially, nausea or vomiting due to chemotherapy influ-
ences the QOL (i.e., activity that might influence presenteeism); therefore supportive 
therapy and instruction to patients for the prevention of the side effects might be more 
improved. We believe that the results would be useful as an exploratory study, but fur-
ther investigations should be conducted in a larger number of patients to clarify the 
influence of the side effects of breast cancer chemotherapy on presenteeism.
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